BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 12790692)

  • 21. [Epilepsy, antiepileptic drugs and disorders of reproductive functions of women].
    Grzyb E; Kwiecińska P; Gregoraszczuk EL
    Przegl Lek; 2014; 71(10):544-8. PubMed ID: 25826979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seizure type, antiepileptic drugs, and reproductive endocrine dysfunction in Indian women with epilepsy: a cross-sectional study.
    Sahota P; Prabhakar S; Kharbanda PS; Bhansali A; Jain V; Das CP; Modi M
    Epilepsia; 2008 Dec; 49(12):2069-77. PubMed ID: 18503558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Polycystic ovary syndrome and valproic acid].
    Ribacoba Montero R; Martínez-Faedo C; Salas-Puig J
    Rev Neurol; 2003 Nov 16-30; 37(10):975-82. PubMed ID: 14634930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women.
    Luef G; Abraham I; Haslinger M; Trinka E; Seppi K; Unterberger I; Alge A; Windisch J; Lechleitner M; Bauer G
    J Neurol; 2002 Jul; 249(7):835-41. PubMed ID: 12140666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reproductive dysfunction in women with epilepsy.
    Isojärvi JI
    Neurology; 2003 Sep; 61(6 Suppl 2):S27-34. PubMed ID: 14504307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Valproate-Induced Polycystic Ovary Syndrome in a Girl with Epilepsy: A Case Study.
    Kawakami Y; Fujii S; Ishikawa G; Sekiguchi A; Nakai A; Takase M
    J Nippon Med Sch; 2018; 85(5):287-290. PubMed ID: 30464147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reproductive function and risk for PCOS in women treated for bipolar disorder.
    Rasgon NL; Altshuler LL; Fairbanks L; Elman S; Bitran J; Labarca R; Saad M; Kupka R; Nolen WA; Frye MA; Suppes T; McElroy SL; Keck PE; Leverich G; Grunze H; Walden J; Post R; Mintz J
    Bipolar Disord; 2005 Jun; 7(3):246-59. PubMed ID: 15898962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Case reports.
    Betts T
    Seizure; 2001 Apr; 10(3):229-34. PubMed ID: 11437624
    [No Abstract]   [Full Text] [Related]  

  • 29. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy.
    Isojärvi JI; Laatikainen TJ; Pakarinen AJ; Juntunen KT; Myllylä VV
    N Engl J Med; 1993 Nov; 329(19):1383-8. PubMed ID: 8413434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A putative relationship between valproic acid and polycystic ovarian syndrome: implications for treatment of women with seizure and bipolar disorders.
    Joffe H; Hall JE; Cohen LS; Taylor AE; Baldessarini RJ
    Harv Rev Psychiatry; 2003; 11(2):99-108. PubMed ID: 12868510
    [No Abstract]   [Full Text] [Related]  

  • 31. Appropriate clinical management of women taking valproate.
    Piontek CM; Wisner KL
    J Clin Psychiatry; 2000 Mar; 61(3):161-3. PubMed ID: 10817097
    [No Abstract]   [Full Text] [Related]  

  • 32. On the association between valproate and polycystic ovary syndrome: a response and an alternative view.
    Isojärvi JI; Taubøll E; Tapanainen JS; Pakarinen AJ; Laatikainen TJ; Knip M; Myllylä VV
    Epilepsia; 2001 Mar; 42(3):305-10. PubMed ID: 11442144
    [No Abstract]   [Full Text] [Related]  

  • 33. Sodium valproate, hyperandrogenism and altered ovarian function in Indian women with epilepsy: a prospective study.
    Prabhakar S; Sahota P; Kharbanda PS; Siali R; Jain V; Lal V; Khurana D
    Epilepsia; 2007 Jul; 48(7):1371-7. PubMed ID: 17441994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of antiepileptic drugs on reproductive endocrine function in individuals with epilepsy.
    Isojärvi JI; Taubøll E; Herzog AG
    CNS Drugs; 2005; 19(3):207-23. PubMed ID: 15740176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered ovarian function and cardiovascular risk factors in valproate-treated women.
    Isojärvi JI; Taubøll E; Pakarinen AJ; van Parys J; Rättyä J; Harbo HF; Dale PO; Fauser BC; Gjerstad L; Koivunen R; Knip M; Tapanainen JS
    Am J Med; 2001 Sep; 111(4):290-6. PubMed ID: 11566460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychiatric disorders related to polycystic ovary syndrome.
    Krępuła K; Bidzińska-Speichert B; Lenarcik A; Tworowska-Bardzińska U
    Endokrynol Pol; 2012; 63(6):488-91. PubMed ID: 23339008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epilepsy therapy: issues for women and men.
    Bauer J
    Curr Opin Neurol; 2001 Apr; 14(2):199-202. PubMed ID: 11262736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Valproate and the polycystic ovarian syndrome: final thoughts.
    Herzog AG; Schachter SC
    Epilepsia; 2001 Mar; 42(3):311-5. PubMed ID: 11442145
    [No Abstract]   [Full Text] [Related]  

  • 39. Reproductive health in patients with epilepsy.
    Markoula S; Siarava E; Keramida A; Chatzistefanidis D; Zikopoulos A; Kyritsis AP; Georgiou I
    Epilepsy Behav; 2020 Dec; 113():107563. PubMed ID: 33242778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reproductive endocrine health in pubertal females with epilepsy on antiepileptic drugs: time to screen?
    Rauchenzauner M; Roscia S; Prieschl M; Wildt L; Haberlandt E; Baumann M; Rostasy K; Agostinelli S; Pizzolorusso A; Luef G; Verrotti A
    Neuropediatrics; 2014 Aug; 45(4):226-33. PubMed ID: 24407471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.